Brief: Sk Pharmteco Announces Strategic Collaboration With Orphan Therapeutics Accelerator
18/06/2026 14:27
BRIEF-Sk Pharmteco Announces Strategic Collaboration With Orphan Therapeutics Accelerator June 18 (Reuters) - SK Inc 034730.KS:
SK PHARMTECO ANNOUNCES STRATEGIC COLLABORATION WITH ORPHAN THERAPEUTICS ACCELERATOR FOR THE DEVELOPMENT AND MANUFACTURING OF RARE DISEASE THERAPIES
Source text: ID:nGNX4GVfKP
Further company coverage: 034730.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SK
See all newsFactbox: Key facts on South Korea's three chip and AI 'mega projects'
SK Hynix explores global financing options for new fabs, may consider overseas investments
Korea taps Samsung, SK Hynix in $576 billion AI-chip drive to cement global leadership (updated)
Samsung Electronics, SK Hynix to invest in two new fabrication sites in South Korea, government says
South Korea unveils mega-project plans for chips, AI data centres